Sustainable Development Goals
This target requires us to call for greater action on the need for a fossil-free chemical industry. We will be advocating for changes that support the transition to circular chemicals and materials. We want to lead by example, and we are demanding from ourselves to step up to address the climate crisis. The scale of the challenge demands that we more actively engage and work through partnerships and collaborations with a broad range of stakeholders.
Your content goes here. Edit or remove this text inline or in the module Content settings. You can also style every aspect of this content in the module Design settings and even apply custom CSS to this text in the module Advanced settings.
As part of our diversity agenda, we believe in gender equality and will strive to achieve this at Avantium. In 2019, 29% of Avantium’s Management Team, 25% of our Leadership Teams and 33% of our Supervisory Board were women. The chemical industry is currently underrepresented by women across all levels of organisations. Avantium compares favourably against the industry average but we know that there is still a lot to do across all levels of the company to achieve gender parity and equality.
Our approach to inspire the next generation of scientists focuses on three actions:
We aim to continuously improve our work environment and culture. We strive to maintain a flat organisation that empowers, recognises and celebrates the many cultures represented. We do this is by making sure we all live and breathe the Avantium values. These values act as our compass and ensure that we are a purpose driven organisation embracing sustainability, wellbeing, diversity and inclusion.
Perform a ‘Great Place to Work’ baseline assessment of workplace to be able to:
We already have a strong safety culture and focus heavily on Health and Safety. We will now begin to embed safety into our systems. We will do this by rolling out ISO45001 across our operations as the gold standard for organisations who are serious about improving employee safety, reducing workplace risks and creating better and safer working conditions.
We will do this by:
In order to achieve zero carbon operations, we will focus on the following areas:
In order to ensure the integrity of our feedstocks, we aim to only partner with suppliers that actively engage in sustainable practices. We will strive to adopt independently certified sustainable standards of feedstock, but when these are not available or appropriate, we will create our own sustainability standards in consultation with subject matter experts and leading NGOs.
Avantium will tackle the circularity challenge with the following approach:
Avantium’s technologies will deliver CO2 savings through:
Trudy Schoolenberg joined the Supervisory Board of the Company in September 2020.
Dr. Trudy Schoolenberg served in various senior management positions at Shell, Wärtsilä and Akzo-Nobel in Research, Operations and Strategy. Dr. Schoolenberg currently holds Senior Independent Director roles at Spirax Sarco Engineering Plc, and Accsys Technologies Plc. Additionally, she is a Non-Eexecutive Director (Bestuurslid) of The Netherlands Petroleum Stockpiling Agency (COVA).
Dr. Schoolenberg has a Ph.D. in Technical Sciences at the Delft University of Technology (The Netherlands) and an Msc in Industrial Engineering. She certified as a Non Execitive Director at ESAA, Erasmus University Rotterdam.
Cynthia Arnold joined the Supervisory Board of the Company in September 2020.
She served as Senior Vice President and Chief Technology Officer at The Valspar Corporation, a manufacturer of paint and coatings. She was also Chief Technology Officer at Sun Chemical Corporation, the world’s largest producer of printing inks and pigments. Prior to this, she worked for nine years at General Electric Plastics, of which three years were for GE Plastics Europe in The Netherlands. She currently serves as a non-executive Director on the Boards of The Cabot Corporation, Milliken & Company and Citrine Informatics.
Dr. Cynthia Arnold holds a Ph.D. from the Virginia Polytechnic Institute & State University in Blacksburg (USA), an MBA from the University of California in Berkeley (USA) and a BS in Chemical Engineering from the University of California in Berkely (USA).
More detailed information about the extraordinary general meeting of shareholders (30 September 2020) can be found here:
CEO Invitation to EGM 2020 >
Convocation notice >
Agenda and explanatory notes EGM Avantium N.V. 30 September 2020 >
Annex I Power of attorney >
Voting results >
Introduction Cynthia Arnold >
Introduction Trudy Schoolenberg >
Questions shareholders >
Minutes EGM 2020 >
Michelle Jou joined the Supervisory Board of the Company in 2020. She has over 20 years of professional experience in the chemical industry in Asia and Europe, where she has served in a variety of positions in sales, marketing and supply chain management. In 2003, Michelle Jou joined Covestro (formerly Bayer MaterialScience) in the company’s central departments in Shanghai. She later took on the role of VP of the Polycarbonates Business Unit in China and Hong Kong. In 2012 Mrs. Jou was named Senior VP of Commercial Operations in the Asia region. In 2016, she became President of Covestro’s global Polycarbonates Segment, headquartered in Shanghai.
Mrs. Michelle B.B. Jou (1969) holds a Bachelor of Arts degree in French from Fu-Jen University (Taiwan) and an MBA from the EMLYON Business School (France). She is fluent in Mandarin, Cantonese, French and English.
Before joining Avantium, Bart Welten served as the CFO of Centrient Pharmaceuticals (formerly the joint-venture of DSM and Sinochem) in Singapore. Before he left Centrient, he managed the sale of the company to Bain Capital. Prior to this, Bart Welten held the position of CFO of DSM Resins and DSM Anti-Infectives. He holds a law degree from Leiden University (Netherlands) and an MBA from Boston College (USA).
Edwin Moses (chairman) joined the Supervisory Board of the Company in December 2019.
Edwin Moses is a serial entrepreneur and value creator in European life science companies. He has expertise in high value service provision to the pharmaceutical industry and in drug discovery and development. His primary focus is on high growth businesses and change management. Mr. Moses has 25 years of Board level experience in more than 10 companies, mostly as Chairman.
Edwin Moses is Chairman of the Supervisory Board , chair of the Nomination Committee, chair of the Remuneration Committee and member of the Audit Committee.